Innovent Biologics Inc. (IVBXF)

PNK: IVBXF · Real-Time Price · USD

5.97

0.00 (0.00%)

At close: Apr 29, 2025, 8:00 PM

Innovent Biologics Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017
Cash & Equivalents	8.17B	10.05B	1.33B	1.02B	1.35B	1.36B	4.46B	1.28B	4.63B	2.43B	3.43B	4.53B	1.89B	510.47M
Short-Term Investments	463.49M	917.53M	6.32B	7.25B	5.68B	6.58B	6.22B	6.77B	1.56B	2.27B	53.5M	82.32M	181.41M	809.48M
Long-Term Investments	2.3B	794.09M	-5.68B	713.22M	465M	511.9M	-6.17B	-6.76B	2.18M	2.22M	n/a	n/a	1.84B	n/a
Other Long-Term Assets	537.42M	1.72B	6.55B	110.04M	78.18M	-4.33B	6.38B	6.91B	-1.66B	251.73M	250.53M	250.31M	-927.93M	135.53M
Receivables	1.37B	1.01B	1.02B	575.27M	1.19B	968.4M	1B	475.38M	380.02M	250.04M	179.78M	-72.81M	n/a	n/a
Inventory	690.41M	968.09M	1.3B	1.43B	1.48B	1.35B	1.1B	705.66M	467.14M	358.6M	231.58M	66.12M	48.98M	57.72M
Other Current Assets	360.55M	484.38M	2.43B	1.81B	2.47B	975.04M	1.48B	548.38M	380.02M	250.04M	333.15M	94.04M	1.72B	66.83M
Total Current Assets	11.05B	13.43B	11.39B	11.51B	11.19B	11.55B	13.43B	9.47B	7.16B	5.46B	4.05B	4.69B	3.84B	1.45B
Property-Plant & Equipment	5.42B	4.66B	4.45B	4.06B	3.61B	3.38B	2.72B	2.18B	1.53B	1.52B	1.31B	1.12B	882.94M	821.84M
Goodwill & Intangibles	987.35M	27.79M	1.19B	1.2B	815.5M	772.19M	96.91M	32.63M	35.21M	n/a	n/a	52.84M	53.47M	54.09M
Total Long-Term Assets	9.25B	7.2B	6.51B	6.08B	4.96B	4.69B	3.02B	2.37B	1.79B	1.78B	1.56B	1.43B	1.06B	1.01B
Total Assets	20.3B	20.63B	17.9B	17.59B	16.16B	16.24B	16.46B	11.83B	8.95B	7.23B	5.61B	6.11B	4.89B	2.46B
Account Payables	220.62M	372.55M	216.41M	325.62M	236.35M	195.05M	277.33M	120.62M	196.06M	84.28M	60.39M	42.82M	36.64M	34.84M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	-1.03B	n/a	n/a	-247.62M	-146.83M	-102.42M	-96.85M	-331.11M	-30.78M
Short-Term Debt	934.65M	1.2B	450.1M	888M	858M	365M	370M	255M	146M	17M	11M	10M	10M	5M
Other Current Liabilities	829.58M	2.02B	1.47B	1.64B	1.9B	1.71B	961.99M	770.07M	529.4M	670M	427.97M	487.9M	146.12M	85.45M
Total Current Liabilities	4.13B	4.48B	2.87B	3.5B	3.48B	3.05B	2.24B	1.49B	1.08B	1.04B	673.46M	670.32M	1.77B	163.28M
Long-Term Debt	2.27B	2.33B	2.89B	2.22B	1.81B	2.02B	1.47B	925.18M	793M	808M	791M	782M	687M	505M
Other Long-Term Liabilities	1.4B	1.22B	1.27B	1.05B	1.19B	342K	n/a	n/a	n/a	n/a	n/a	n/a	477.27M	371.19M
Total Long-Term Liabilities	3.74B	3.62B	4.24B	3.36B	3.09B	2.86B	2.31B	1.57B	1.46B	1.43B	1.4B	1.25B	4.7B	3.92B
Total Liabilities	7.87B	8.1B	7.11B	6.86B	6.57B	5.91B	4.55B	3.06B	2.55B	2.47B	2.08B	1.92B	6.47B	4.08B
Total Debt	3.35B	3.62B	3.45B	3.23B	2.77B	2.5B	1.86B	1.21B	970.85M	865.09M	823.68M	792M	697M	510M
Common Stock	112K	112K	106K	105K	101K	101K	100K	97K	93K	87K	79K	79K	14K	8K
Retained Earnings	-16.16B	-15.77B	-14.88B	-16.68B	-15.82B	-15.41B	-11.16B	-9.98B	-10.52B	-10.05B	-9.08B	-8.27B	-1.72B	-1.79B
Comprehensive Income	1.04B	n/a	761.76M	763.86M	558.15M	397.02M	595.2M	220.41M	7.17M	-145.65M	-248.43M	-293.29M	-304.42M	-504.64M
Shareholders Equity	12.43B	12.53B	10.78B	10.73B	9.59B	10.33B	11.91B	8.78B	6.4B	4.76B	3.53B	4.19B	-1.57B	-1.94B
Total Investments	2.76B	794.09M	636.65M	630.2M	397.05M	417.25M	45.43M	12.94M	1.98M	1.98M	53.5M	82.32M	2.02B	809.48M